MedTrace Logo

The Effect of the Use of Sterile Transparent Film Dressing in Newborns

NCT05694390 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2023-01-23

No results posted yet for this study

Summary

It is important that effective catheter fixation will reduce the risk of catheter unavailability for specific reasons and the incidence of catheter-related complications. The aim of this study was to determine the effect of sterile transparent film dressing and tape methods used in pe- ripheral intravenous catheter application in newborns on the duration of catheter stay and the development of catheter-related complications.

Conditions

  • Newborn
  • Peripheral Venous Catheterization

Interventions

OTHER

Use of sterile transparent film dressing

The nurses in the unit were trained by the charge nurse of the clinic on catheter-related complications (infiltration, extravasation, phlebitis, and occlusion), the scales used in the study, and the use of sterile transparent film dressing. In the experimental group, a sterile transparent film dressing was used to fix the catheter and was monitored hourly until the catheter was removed. The infiltration scale for infants, , the criteria of extravasation (Redness accompanied by a vesicle, tissue necrosis, and ulcer), and The Phlebitis Scale were used to evaluate the catheter site.

Sponsors & Collaborators

  • Yuksek Ihtisas Hospital

    lead OTHER

Principal Investigators

  • Suzan YILDIZ, PhD · Istanbul University - Cerrahpasa

  • Yağmur GÜL, BSN · Istanbul Florence Nightingale Hospital

  • Ozan UZUNHAN, MD · Istanbul Florence Nightingale Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05694390 on ClinicalTrials.gov